BRESSON J L ET AL: "Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial" LANCET THE, LANCET LIMITED. LONDON, GB, vol. 367, no. 9523, 20 May 2006 (2006-05-20), pages 1657-1664, XP025094558 ISSN: 0140-6736 [retrieved on 2006-05-20] (B1)

Yang et al., PLoS ONE, 2012 (B2)

DATABASE BIOSIS [Online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US April 2008 HOELSCHER MARY A ET AL: 'A broadly protective vaccine against globally dispersed clade 1 and clade 2 H5N1 influenza viruses' Database accession no. PREV200800353107 & JOURNAL OF INFECTIOUS DISEASES, vol. 197, no. 8, April 2008 (2008-04), pages 1185-1188, ISSN: 0022-1899, DOI: DOI:10.1086/529522 (B1)

DATABASE MEDLINE [Online] US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US; 2003, HAAHEIM L R: "Original antigenic sin. A confounding issue?" XP002519290 Database accession no. NLM15088775 cited in the application & DEVELOPMENTS IN BIOLOGICALS 2003, vol. 115, 2003, pages 49-53, ISSN: 1424-6074 (B1)

KEITEL ET AL: "Preparing for a possible pandemic: influenza A/H5N1 vaccine development" CURRENT OPINION IN PHARMACOLOGY, ELSEVIER SCIENCE PUBLISHERS, NL, vol. 7, no. 5, 1 October 2007 (2007-10-01), pages 484-490, XP022300861 ISSN: 1471-4892 (B1)

PLOS ONE vol. 3, 18 June 2008, page E2432 (B1)

STEPHENSON I ET AL: "Boosting immunity to influenza H5N1 with MF59-adjuvanted H5N3 A/Duck/Singapore/97 vaccine in a primed human population" VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, vol. 21, no. 15, 2 April 2003 (2003-04-02), pages 1687-1693, XP004413557 ISSN: 0264-410X (B1)

STEPHENSON IAIN ET AL: "Antigenically distinct MF59-adjuvanted vaccine to boost immunity to H5N1." THE NEW ENGLAND JOURNAL OF MEDICINE 9 OCT 2008, vol. 359, no. 15, 9 October 2008 (2008-10-09), pages 1631-1633, XP002519289 ISSN: 1533-4406 cited in the application (B1)

STEPHENSON IAIN ET AL: "Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteers" JOURNAL OF VIROLOGY, vol. 80, no. 10, May 2006 (2006-05), pages 4962-4970, XP002519288 ISSN: 0022-538X (B1)

VACCINE vol. 27, 09 May 2009, pages 4187 - 4195 (B1)

VIROLOGY JOURNAL vol. 5, October 2008, pages 1 - 9 (B1)

Vilamoura EIC Conference, September 2008. Kistner et al, 'Induction of cross-clade anti-H5N1 immune responses...' (B1)

Belsheet al., JID, 2011 (B2)

Crevar et al., Vir. J 2008 (B2)

Emerging Infectious Diseases Volume 14, Number 7, July 2008 online publication ? Towards a Unified Nomenclature System for Highly Pathogenic Avian Influenza Virus (HSN 1), available at: http://wwwnc.cdc.gOv/eid/article/14/7/07- 1681 a rticle.htm (B2)

European Centre for Disease Prevention and Control (ECDC) Technical Report, Expert Advisory Groups on human HSN1 vaccines, August 2007 (B2)

Eurosurveillance, Volume 12, issue 38, 20 September 2007. Available at:http.7/www.eurosurveillance.org]ViewArt icle.aspx?Articleld=3272uh (B2)

Forrest et al., Vaccine, 2009 (B2)

Fragapane et al., Clinical and Vaccine Immunology, 2010 (B2)

Galli et al.. PNAS 2009 (B2)

Gillard et al., BMC Infectious Diseases 2014 (B2)

Goji et al 2008, The Journal of Infectious Diseases 198:635-41 (B2)

Govorkova et al., 2006; The Journal of Infectious Diseases 194:159-67 (B2)

Hoelscher et al, JID, 2008 (B2)

Kistner et al, 2008 (B2)

Kistner et al., 2007, Vaccine 25: 6028-6036 (B2)

Leroux-Roels et al, Lancet August 2007; 370:580-89 (B2)

Li and Huangiuly-August 2007 Chang Gung Med J Vol 30, No.4 (B2)

NIH press release ?NIH News" dated 12 October 2006 (B2)

Nolan et al., October 2006 (B2)

PCT Request Form (B2)

Plotkin & Mortimer, Chapter 17, 4th Edition, ?Inactivated Influenza Vaccines" (B2)

Sanofi Pasteur datasheet (B2)

Schwarz et al. (Pepandrix) (B2)

Stephenson et al 2005 Expert Rev. Vaccines 4(2) p151-155 (B2)

Stephenson et al., 2003 Vaccine 21: 1687-1693 (B2)

Stephenson et al., NEJM , 2008 (B2)

Treanor et al., 2001 Vaccine 19:1732-1737 (B2)

Treanoret al., 2006, New England Journal of Medicine 354(13): 1343-1351 (B2)

Van der Velden et al., Vaccine 2012 (B2)

WHO October 2011 online publication ?Updated unified nomenclaturesystem for the highly pathogenic H5N1 avian influenza viruses" found athttp://wwwwho.int/influenza/gisrs aboratory/hSnl nomenclature/en/#. See fulldate tree diagram provided in this publication, downloadable under link to "Fulltree (Ja (B2)

WO-A1-2006/100109 (B2)

WO-A1-2006/100110 (B2)

WO-A1-2008/009309 (B2)

WO-A2-2007/130330 (B2)

Cannes IVW Conference, April 2009 Schwarz et al, 'Single dose primary vaccination...' (B1)